MOREPENLAB Morepen Laboratories Ltd Expansion Plans Announcement 2025 - Loratadine Approval Morepen Laboratories Ltd has received approval to export its Loratadine anti-allergy drug to China, marking a strategic expansion into a major pharmaceutical market and confirming their dominance in the US generics market with over 80% share. This approval is significant as it reinforces Morepen's leadership in global healthcare and its capacity to meet growing demand in China..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Morepen Laboratories Ltd